This 3-part series has reviewed the financial impact of SSIs and emerging trends in SSI prevention. It is well accepted that hospital-acquired infection (HAI) after surgery or insertion of a device increases morbidity, mortality, and costs of care for patients and hospitals. Emerging trends in SSI prevention include antimicrobial dressings, with the purpose of protecting…
Welcome to the second blog in this 3-part series about SSIs. In the last blog, the substantial financial impact of SSIs was presented (see Blog #1 of the series). Knowing that the US Centers for Medicare and Medicaid Services (CMS) are no longer reimbursing hospitals for HAIs like SSI1, healthcare professionals are under tremendous pressure…
Welcome to a new 3-part series focusing on SSIs. SSIs are the most common type of hospital-acquired infection (HAI). They occur an estimated 160,000 to 300,000 times per year and account for more than 20% of all HAIs.1 And while the negative clinical outcomes associated with SSIs (ie, morbidity and mortality) are commonly known, there…
The previous blog of this 2‐part series focused on Left Ventricular Assist Devices (LVADs), including the prevalence of use, the types of patients treated, and the associated risks of LVAD‐associated infections. (View Blog 1 of 2) Part 2 of the series will focus on minimizing driveline infections once the patient goes home. LVADs have revolutionized…
Welcome to the first of a 2-part series on Left Ventricular Assist Devices (LVADs). Part 1 will provide an overview of LVADs, types of patients treated and the associated risks. Congestive Heart Failure (CHF) is a leading cause of death worldwide. CHF is estimated to impact over 20 million people in the world, 2.2 million…
For the last ten years, Eloquest Healthcare Inc. has put an emphasis on giving back to the community. It is something we do as an organized team, and also something we encourage our employees to do as individuals in their communities. As individuals, philanthropy and volunteering can have a significant impact on our lives. Unlike…